Tech Company Financing Transactions
KGK Science Funding Round
On 7/27/2026, KGK Science raised funding from Maxim Group and private investors.
Transaction Overview
Company Name
Announced On
7/27/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Maxim Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support expanded clinical trial capacity, continued investment in decentralized and virtual trial capabilities, growth of its regulatory services, and continued expansion of its commercial organization.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
275 Dundas St. G02
London, ON, N6B 3L1
Canada
London, ON, N6B 3L1
Canada
Phone
Undisclosed
Website
Email Address
Overview
KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical industry, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/27/2026: Fly.io venture capital transaction
Next: 7/27/2026: Nuclear Turbines venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








